Lexicon Pharmaceuticals | LXRX - EPS Earnings Per Share


Lexicon Pharmaceuticals reported $-0.04 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
Abbott USD 1.5 0.2 Dec/2025
Acadia Pharmaceuticals USD 1.6 1.18 Dec/2025
Agios Pharmaceuticals USD -1.86 0.08 Dec/2025
Akebia Therapeutics USD -0.04 0.04 Dec/2025
Alnylam Pharmaceuticals USD 1.25 1.65 Dec/2025
AstraZeneca USD 2.12 0.26 Dec/2025
BioMarin Pharmaceutical USD 0.46 0.34 Dec/2025
Coherus Biosciences USD -0.43 0.06 Dec/2025
Eli Lilly USD 7.54 0.52 Dec/2025
Esperion Therapeutics USD 0.26 0.42 Dec/2025
Halozyme Therapeutics USD -0.24 1.96 Dec/2025
Illumina USD 1.35 0.01 Dec/2025
Insmed USD -1.54 0.21 Dec/2025
Ironwood Pharmaceuticals USD -0.01 0.25 Dec/2025
J&J USD 2.46 0.34 Dec/2025
Lexicon Pharmaceuticals USD -0.04 0.01 Dec/2025
MacroGenics USD -0.22 0.49 Dec/2025
MannKind USD 0.01 0.06 Dec/2025
Merck USD 2.04 0.54 Dec/2025
Moderna USD -2.11 1.6 Dec/2025
Novartis USD 1.54 0.5 Dec/2025
PTC Therapeutics USD -1.67 1.87 Dec/2025
Puma Biotechnology USD 0.41 0.5 Sep/2024
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
Thermo Fisher Scientific USD 6.57 0.78 Dec/2025
Ultragenyx Pharmaceutical USD -1.29 0.52 Dec/2025
United Therapeutics USD 7.7 0.54 Dec/2025
Vanda Pharmaceuticals USD -0.09 0 Dec/2024